You are here: Home » Companies » Industry
Business Standard

As trade war with US intensifies, China opens door to Indian pharma

Swift regulatory approvals in China would allow Indian companies to boost revenue at a time when pricing scrutiny and regulatory troubles have hurt US sales

Reuters  |  New Delhi 

China is preparing to give swift regulatory approvals to India-manufactured drugs, the head of an Indian export promotion group said, as Beijing looks for new commercial partners ahead of what could be a protracted trade war with the United States. Indian firms are looking to fill gaps in Chinese demand for generic drugs, software, sugar and some varieties of rice, trade officials in New Delhi said. "We do feel that China is receptive at this time and it's all about making prices competitive," said a government official involved in the effort to promote trade with ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, July 12 2018. 15:19 IST
RECOMMENDED FOR YOU